Targeted Radiotherapy of the Tumor Cavity after Surgical Resection of Aggressive Recurrent Brain Metastasis: A Case Report.

Brain metastases Local control Radiotherapy

Journal

Case reports in oncology
ISSN: 1662-6575
Titre abrégé: Case Rep Oncol
Pays: Switzerland
ID NLM: 101517601

Informations de publication

Date de publication:
Historique:
received: 26 01 2020
accepted: 28 01 2020
entrez: 21 4 2020
pubmed: 21 4 2020
medline: 21 4 2020
Statut: epublish

Résumé

Postoperative management of patients with brain metastases is controversial. Besides local control, cognitive function and quality of life are the most important outcomes of postoperative radiotherapy. In this case report, we introduce a patient with aggressive recurred solid metastasis treated with repeated surgery and an individual radiotherapy approach in order to highlight that close mutual collaboration leads to a clear benefit for our patients. The local targeted radiotherapy with 35 Gy in 10 fractions was performed with the volumetric modulated arc technique, leading to more than 2.5 years of local control and survival without any of the side effects usually attributed to whole brain radiotherapy.

Identifiants

pubmed: 32308582
doi: 10.1159/000506328
pii: cro-0013-0233
pmc: PMC7154243
doi:

Types de publication

Case Reports

Langues

eng

Pagination

233-238

Informations de copyright

Copyright © 2020 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Nat Rev Dis Primers. 2019 Jan 17;5(1):5
pubmed: 30655533
Klin Onkol. 2015;28(5):352-8
pubmed: 26480863
J Neurooncol. 2019 Sep;144(2):343-350
pubmed: 31313060
Neurosurgery. 2019 Mar 1;84(3):E152-E155
pubmed: 30629227
Neoplasma. 2017;64(3):329-337
pubmed: 28253711
Curr Treat Options Oncol. 2019 May 6;20(6):49
pubmed: 31062107
Lancet Oncol. 2017 Aug;18(8):1040-1048
pubmed: 28687375
Lancet Oncol. 2017 Aug;18(8):1049-1060
pubmed: 28687377
Radiat Oncol. 2014 Jun 16;9:139
pubmed: 24935286
N Engl J Med. 2018 Aug 23;379(8):722-730
pubmed: 30134131

Auteurs

Pavel Fadrus (P)

Department of Neurosurgery, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.

Tomas Kazda (T)

Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czechia.

Petr Dvoracek (P)

Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.

Petr Pospisil (P)

Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czechia.

Ludmila Hynkova (L)

Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czechia.

Jana Zitterbartova (J)

Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czechia.

Radana Dymackova (R)

Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czechia.

Ivana Kolouskova (I)

Faculty of Medicine, Masaryk University, Brno, Czechia.

Renata Belanova (R)

Faculty of Medicine, Masaryk University, Brno, Czechia.
Department of Radiology, Masaryk Memorial Cancer Institute, Brno, Czechia.

Tomas Prochazka (T)

Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czechia.

Pavel Slampa (P)

Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Brno, Czechia.

Classifications MeSH